Discover
AVXL
Anavex Life Sciences Corp.
2.42
2 x 1.74
2 x 3.09
bid
ask
+
0.01
0.41%
2 @ 07:30 PM
2.42 +0.00 (0.00%)
| Ytd | -32.02% | |
| 1y | -72.09% |
2.38
day range
2.44
2.34
52 week range
9.96
| Open | 2.40 | Prev Close | 2.41 | Low | 2.38 | High | 2.44 | Mkt Cap | 224.33M |
| Vol | 920.59K | Avg Vol | 923.58K | EPS | -0.14 | P/E | N/A | Forward P/E | -17.25 |
| Beta | 0.60 | Short Ratio | 10.82 | Inst. Own | 32.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-24 | 50-d Avg | 2.85 | 200-d Avg | 3.45 | 1yr Est | 35.47 |
| Income Statement | |||
| Operating Expenses | -6.74M | ||
| Research and Development Expense | -4.70M | ||
| Selling, General and Administrative Expense | -2.03M | ||
| Operating Income | 6.74M | ||
| Net Income | 7.82M | ||
| Net Income Common Stock | 7.82M | ||
| Net Income Common Stock (USD) | 7.82M | ||
| Consolidated Income | 7.82M | ||
| Earnings per Basic Share | 0.08 | ||
| Earnings per Basic Share (USD) | 0.08 | ||
| Earnings per Diluted Share | 0.08 | ||
| Earning Before Interest & Taxes (EBIT) | 7.82M | ||
| Earning Before Interest & Taxes (USD) | 7.82M | ||
| Weighted Average Shares | 92.70M | ||
| Weighted Average Shares Diluted | 92.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 118.33M | ||
| Cash and Equivalents (USD) | 118.33M | ||
| Current Assets | 120.14M | ||
| Total Assets | 120.14M | ||
| Current Liabilities | 7.69M | ||
| Total Liabilities | 7.69M | ||
| Accumulated Retained Earnings (Deficit) | -385.64M | ||
| Shareholders Equity | 112.45M | ||
| Shareholders Equity (USD) | 112.45M | ||
| Trade and Non-Trade Payables | 3.66M | ||
| Tax Assets | 995.00K | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.10M | ||
| Net Cash Flow from Operations | -9.10M | ||
| Share Based Compensation | -17.08M | ||